Novel Anti-Microbial/Anti-Inflammatory Combination Improves Clinical Outcome of Bacillus cereus Endophthalmitis.

Novel Anti-Microbial/Anti-Inflammatory Combination Improves Clinical Outcome of Bacillus cereus Endophthalmitis. Invest Ophthalmol Vis Sci. 2025 Jan 02; 66(1):39.

View in: PubMed

subject areas

Animals
Anti-Bacterial Agents
Anti-Inflammatory Agents
Bacillus cereus
Disease Models, Animal
Drug Therapy, Combination
Electroretinography
Endophthalmitis
Eye Infections, Bacterial
Female
Gram-Positive Bacterial Infections
Mice
Mice, Inbred C57BL
Retina
Toll-Like Receptor 2
Toll-Like Receptor 4
Treatment Outcome

authors with profiles

Michelle C Callegan
Phillip Stephen Coburn
Luis Enrique Longoria Gonzalez